Skip to main content
. Author manuscript; available in PMC: 2009 Oct 1.
Published in final edited form as: Neuropeptides. 2008 Nov 7;42(5-6):601–609. doi: 10.1016/j.npep.2008.09.003

Table 2.

Effects of the conantokins on formalin-induced edemaa

Peptides b Injected paw width a (mm)
Before formalin injection After formalin injectionc Increase in paw width
con-G* 1.55 ± 0.02 2.38 ± 0.03 0.83 ± 0.03
con-G[S16Y]* 1.57 ± 0.03 2.33 ± 0.05 0.76 ± 0.05
Ala-con-G 1.60 ± 0.02 2.56 ± 0.05 0.97 ± 0.05
con-R[1-17] 1.60 ± 0.04 2.60 ± 0.05 1.00 ± 0.08
ifenprodil 1.59 ± 0.04 2.70 ± 0.04 1.10 ± 0.05
saline 1.57 ± 0.03 2.53 ± 0.03 0.97 ± 0.05
a

Edema was elicited through injection of 20 μl of 5% formalin in saline into the subplantar region of the right hind paw. Data are presented as mean ± S.D. (n = 8).

b

Peptides (100 pmol) or ifenprodil (25 nmol) were injected intracerebrally (i.c.v.) in a volume of 20 μl.

c

Measurements were taken 60 min after formalin injection.

*

Significantly diminished paw swelling compared to the saline control group (p < 0.05, unpaired t test).